Menu

Eisai's hhc Concept
Innovation
Back
Innovation
Research and Development (R&D)

hhceco (the hhc Concept + ecosystem)

Open Innovation

Corporate Venture Capital
Back
Research and Development (R&D)
News Release

Worldwide

Japanese

Contact Us
Back
hhceco (the hhc Concept + ecosystem)
- Collaboration with Other Industries and Local Municipalities
- Collaborations with Partners on Blood Biomarkers
News Release

Worldwide

Japanese

Contact Us
Investors
Back
Investors
Management Policy

IR Library

Financial Data

IR Events

Stock & Bond Information

E-Mail Alerts
Back
Management Policy
News Release

Worldwide

Japanese

Contact Us
Back
IR Library
News Release

Worldwide

Japanese

Contact Us
Back
Financial Data
News Release

Worldwide

Japanese

Contact Us
Back
Stock & Bond Information
News Release

Worldwide

Japanese

Contact Us
Sustainability
Back
Sustainability
Message from Top Management

Eisai's Sustainability

Sustainability Management

Initiatives for Improving Access to Medicines

Environment

Society

Social Impact Creation Model

Governance

ESG Data & Report

Third-Party Assessment
Back
Sustainability Management
News Release

Worldwide

Japanese

Contact Us
Back
Initiatives for Improving Access to Medicines
News Release

Worldwide

Japanese

Contact Us
Back
Environment
News Release

Worldwide

Japanese

Contact Us
Back
Society
News Release

Worldwide

Japanese

Contact Us
Back
Governance
News Release

Worldwide

Japanese

Contact Us
Back
ESG Data & Report
News Release

Worldwide

Japanese

Contact Us
About Eisai
Back
About Eisai
Message from Top Management

Corporate Concept

Corporate Information

Corporate Governance

Business Activities

Video Library

Eisai at a Glance
Back
Corporate Information
News Release

Worldwide

Japanese

Contact Us
Back
Corporate Governance
News Release

Worldwide

Japanese

Contact Us
Back
Business Activities
- Products
- Production and Logistics (Demand Chain Systems)
News Release

Worldwide

Japanese

Contact Us

News Release
Worldwide
Japanese
Contact Us

Home
News Release
2025 Release
Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma

Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to
Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma

For Print
August 29, 2025

Full text

News release search

News Release

2025 Release
2024 Release
2023 Release
2022 Release
2021 Release
2020 Release
2019 Release
2018 Release
2017 Release
2016 Release
2015 Release
2014 Release
2013 Release
2012 Release
2011 Release
2010 Release
2009 Release
2008 Release
2007 Release

Eisai'shhcConcept

Mission and Results
“Socialization” is Key to Conceiving and Implementing Our Activities
hhcDriven Innovation Activities (hhcActivities)
hhcActivities
Empowering People to Realize Their Fullest Life

Research and Development (R&D)
Ecosystem
Open Innovation
Corporate Venture Capital

Management Policy
IR Library
Financial Data
IR Events
Stock & Bond Information
E-Mail Alerts

Eisai's Sustainability
Sustainability Management
Improving Access to Medicines
Environment
Society
Social Impact Creation Model
Governance
ESG Data & Report
Third-Party Assessment

Message from Top Management
Corporate Mission
Corporate Information
Corporate Governance
Business Activities
Video Library
Eisai at a Glance

Sitemap
Privacy Policy
External Data Transmission
Terms of Use
Recommended Environment
SNS Community Guidelines
Accessibility

Follow us on:

Copyright © Eisai Co., Ltd. All Rights Reserved.

This website uses cookies to enhance your browsing experience. By using this site, you agree to our use of cookies. If you do not wish to accept cookies in connection with your use of this website, you may change your browser settings to block the acceptance of cookies. Please refer to the “External Data Transmission” section for further information.